Microcomputed tomography
is an important technique for distinguishing
the vascular network from tissues with similar X-ray attenuation.
Here, we describe a composite of barium sulfate (BaSO4)
nanoparticles, calcium carbonate (CaCO3) nanoparticles,
and alginate that provides improved performance over microscale BaSO4 particles, which are currently used clinically as X-ray contrast
agents. BaSO4 and CaCO3 nanoparticles were synthesized
using a polyol method with tetraethylene glycol as solvent and capping
agent. The nanoparticles show good colloidal stability in aqueous
solutions. A deliverable nanocomposite gel contrast agent was produced
by encapsulation of the BaSO4 and CaCO3 nanoparticles
in an alginate gel matrix. The gelation time was controlled by addition
of d-(+)-gluconic acid δ-lactone, which controls the
rate of dissolution of the CaCO3 nanoparticles that produce
Ca2+ which cross-links the gel. Rapid cross-linking of
the gel by Ba2+ was minimized by producing BaSO4 nanoparticles with an excess of surface sulfate. The resulting BaSO4–CaCO3 nanoparticle alginate gel mechanical
properties were characterized, including the gel storage modulus,
peak stress and elastic modulus, and radiodensity. The resulting nanocomposite
has good viscosity control and good final gel stiffness. The nanocomposite
has gelation times between 30 and 35 min, adequate for full body perfusion.
This is the first nanoscale composite of a radiopaque metal salt to
be developed in combination with an alginate hydrogel and designed
for medical perfusion and vascular imaging applications.